These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 17662396)

  • 41. Noncontact mapping and radiofrequency catheter ablation of fast and hemodynamically unstable ventricular tachycardia after surgical repair of tetralogy of Fallot.
    Kriebel T; Saul JP; Schneider H; Sigler M; Paul T
    J Am Coll Cardiol; 2007 Nov; 50(22):2162-8. PubMed ID: 18036455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Substrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation.
    Volkmer M; Ouyang F; Deger F; Ernst S; Goya M; Bänsch D; Berodt K; Kuck KH; Antz M
    Europace; 2006 Nov; 8(11):968-76. PubMed ID: 17043071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in the isolated delayed component as an endpoint of catheter ablation in arrhythmogenic right ventricular cardiomyopathy: predictor for long-term success.
    Nogami A; Sugiyasu A; Tada H; Kurosaki K; Sakamaki M; Kowase S; Oginosawa Y; Kubota S; Usui T; Naito S
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):681-8. PubMed ID: 18284499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ventricular tachycardia late after repair of congenital heart disease: efficacy of combination therapy with radiofrequency catheter ablation and class III antiarrhythmic agents and long-term outcome.
    Furushima H; Chinushi M; Sugiura H; Komura S; Tanabe Y; Watanabe H; Washizuka T; Aizawa Y
    J Electrocardiol; 2006 Apr; 39(2):219-24. PubMed ID: 16580423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis during sinus rhythm and ventricular pacing of reentry circuit isthmus sites in right ventricular cardiomyopathy.
    Reithmann C; Ulbrich M; Hahnefeld A; Huber A; Matis T; Steinbeck G
    Pacing Clin Electrophysiol; 2008 Dec; 31(12):1535-45. PubMed ID: 19067805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prognosis and long-term development of arrhythmogenic dysplasia of the right ventricle].
    Canu G; Atallah G; Claudel JP; Champagnac D; Desseigne D; Chevalier P; de Zuloaga C; Moncada E; Kirkorian G; Touboul P
    Arch Mal Coeur Vaiss; 1993 Jan; 86(1):41-8. PubMed ID: 8338399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Precordial QRS amplitude ratio predicts long-term outcome after catheter ablation of electrical storm due to ventricular tachycardias in patients with arrhythmogenic right ventricular cardiomyopathy.
    Müssigbrodt A; Dinov B; Bertagnoli L; Sommer P; Richter S; Breithardt OA; Rolf S; Bollmann A; Hindricks G; Arya A
    J Electrocardiol; 2015; 48(1):86-92. PubMed ID: 25465865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ventricular tachycardia in nonpostoperative pediatric patients: role of radiofrequency catheter ablation.
    Laohakunakorn P; Paul T; Knick B; Blaufox AD; Long B; Saul JP
    Pediatr Cardiol; 2003; 24(2):154-60. PubMed ID: 12457254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study.
    Berruezo A; Acosta J; Fernández-Armenta J; Pedrote A; Barrera A; Arana-Rueda E; Bodegas AI; Anguera I; Tercedor L; Penela D; Andreu D; Perea RJ; Prat-González S; Mont L
    Europace; 2017 Apr; 19(4):607-616. PubMed ID: 28431051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epicardial ablation for ventricular tachycardia: a European multicenter study.
    Della Bella P; Brugada J; Zeppenfeld K; Merino J; Neuzil P; Maury P; Maccabelli G; Vergara P; Baratto F; Berruezo A; Wijnmaalen AP
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):653-9. PubMed ID: 21841191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Catheter ablation of ventricular tachycardia in nonischemic heart disease.
    Tokuda M; Tedrow UB; Kojodjojo P; Inada K; Koplan BA; Michaud GF; John RM; Epstein LM; Stevenson WG
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):992-1000. PubMed ID: 22942218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Exercise on Outcome after Ventricular Tachycardia Ablation in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Müssigbrodt A; Czimbalmos C; Stauber A; Bertagnolli L; Bode K; Dagres N; Döring M; Richter S; Sommer P; Husser D; Bollmann A; Hindricks G; Arya A
    Int J Sports Med; 2019 Sep; 40(10):657-662. PubMed ID: 31342478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars.
    Soejima K; Stevenson WG; Sapp JL; Selwyn AP; Couper G; Epstein LM
    J Am Coll Cardiol; 2004 May; 43(10):1834-42. PubMed ID: 15145109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Catheter ablation of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy.
    Laredo M; Oliveira Da Silva L; Extramiana F; Lellouche N; Varlet É; Amet D; Algalarrondo V; Waintraub X; Duthoit G; Badenco N; Maupain C; Hidden-Lucet F; Maury P; Gandjbakhch E;
    Heart Rhythm; 2020 Jan; 17(1):41-48. PubMed ID: 31284048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiofrequency ablation of accessory pathways: a 14 year experience at the Tel Aviv Medical Center in 508 patients.
    Belhassen B; Rogowski O; Glick A; Viskin S; Ilan M; Rosso R; Eldar M
    Isr Med Assoc J; 2007 Apr; 9(4):265-70. PubMed ID: 17491219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ventricular tachycardia ablation: evolution of patients and procedures over 8 years.
    Sacher F; Tedrow UB; Field ME; Raymond JM; Koplan BA; Epstein LM; Stevenson WG
    Circ Arrhythm Electrophysiol; 2008 Aug; 1(3):153-61. PubMed ID: 19808409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-Term Outcomes of Radio-Frequency Catheter Ablation on Ventricular Tachycardias Due to Arrhythmogenic Right Ventricular Cardiomyopathy: A Single Center Experience.
    Wei W; Liao H; Xue Y; Fang X; Huang J; Liu Y; Deng H; Liang Y; Liao Z; Liu F; Lin W; Zhan X; Wu S
    PLoS One; 2017; 12(1):e0169863. PubMed ID: 28122031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myocardial voltage ratio in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Müssigbrodt A; Bertagnolli L; Efimova E; Kosiuk J; Dinov B; Bode K; Kircher S; Dagres N; Döring M; Richter S; Sommer P; Husser D; Bollmann A; Hindricks G; Arya A
    Herzschrittmacherther Elektrophysiol; 2017 Jun; 28(2):219-224. PubMed ID: 28536891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ventricular tachycardia originating from the posterior papillary muscle in the left ventricle: a distinct clinical syndrome.
    Doppalapudi H; Yamada T; McElderry HT; Plumb VJ; Epstein AE; Kay GN
    Circ Arrhythm Electrophysiol; 2008 Apr; 1(1):23-9. PubMed ID: 19808390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of radiofrequency catheter ablation of right ventricular outflow tract tachycardia using the CARTO system.
    Pruszkowska-Skrzep P; Kalarus Z; Sredniawa B; Lenarczyk R; Kowalski O; Musialik-Łydka A; Stabryła-Deska J; Prokopczuk J; Sliwińska A
    Kardiol Pol; 2005 Feb; 62(2):138-44. PubMed ID: 15815797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.